To date, only one drug, the small-molecule tafamidis, has been developed to interfere with this cascade, but tafamidis is limited to treating amyloidosis specifically driven by aggregation of the ...

Oliviero Toscani, the famous photographer, is in the hospital for amyloidosis. His story of courage and determination.

Oliviero Toscani and his battle against amyloidosis. Oliviero Toscani, a well-known Italian photographer and artist, was ...

A photographer and art director, he broke the boundaries of advertising in the 1980s and ’90s, embracing activism with images ...

Alnylam Pharmaceuticals ALNY announced preliminary net product revenues for the fourth quarter and full-year 2024 for its ...

Intellia expects to incur charges of $8m associated with the reorganisation, which will likely be incurred in Q1 2025.

Multiple myeloma and AL amyloidosis are conditions linked to plasma cells in the bone marrow. Multiple myeloma (MM) is a cancer affecting the plasma cells, which are mostly in the bone marrow.

Several case reports and retrospective cohort studies have described a marginal benefit with the use of internal cardioverter defibrillators in patients with cardiac amyloidosis. Detection of ...

Immix Biopharma (IMMX) announced completion of the six-patient Phase 1b safety run-in segment in the U.S. NEXICART-2 study of NXC-201, an ...

Tolcapone is under clinical development by Corino Therapeutics and currently in Phase II for Amyloidosis. According to GlobalData, Phase II drugs for Amyloidosis have a 72% phase transition success ...

Oliviero Toscani, the visionary photographer known for Benetton's controversial ad campaigns in the 90s, passed away at 82. Toscani, who had amyloidosis, was celebrated for his provocative work ...

Successfully dosed 6 patients in safety run-in segment, now accelerating enrollmentPositive data from first four patients announced December ...